¼¼°èÀÇ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Digital Patient Monitoring Devices
»óǰÄÚµå : 1768439
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 174 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,225,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,675,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2030³â±îÁö 5,378¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1,982¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024-2030³â¿¡ CAGR 18.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 5,378¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¿þ¾î·¯ºí µð¹ÙÀ̽º´Â CAGR 18.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1,880¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸ð¹ÙÀÏ Çコ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 21.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 504¾ï ´Þ·¯·Î ÃßÁ¤µÇ¾î Áß±¹Àº CAGR 23.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â¿¡ 504¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1,420¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 23.7%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 13.0%¿Í 15.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ¾î¶»°Ô ÇコÄɾ Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë ÀÇ·á ½Ã½ºÅÛ¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® ÀâÀ¸¸ç ȯÀÚÀÇ °Ç°­ »óŸ¦ ÃßÀûÇÏ°í °ü¸®ÇÏ´Â ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â »ýü ½ÅÈ£, ½Åü Ȱµ¿ ¹× ±âŸ °Ç°­ ¸Å°³ º¯¼ö¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ¸ç, Àû½Ã¿¡ ºÐ¼® ¹× °³ÀÔÀ» À§ÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ Àü¼ÛÇÏ¿© Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ½º¸¶Æ® ¿öÄ¡, ÇÇÆ®´Ï½º Æ®·¡Ä¿, ¿¬¼Ó Ç÷´ç ¸ð´ÏÅÍ ¹× ½ÉÀüµµ ¸ð´ÏÅÍ¿Í °°Àº °í±Þ ÀÇ·á¿ë Àåºñ¿Í °°Àº ¿þ¾î·¯ºí ±â±âÀÇ ÃâÇöÀ¸·Î ȯÀÚ ¸ð´ÏÅ͸µÀÌ ´õ¿í Ä£¼÷Çϰí, °³ÀÎÈ­µÇ°í, Á¤È®ÇØÁ³½À´Ï´Ù. µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â º´¿ø, ÀÚÅÃ, ¿ø°ÝÁö µî ¾î´À °÷¿¡¼­³ª Áö¼ÓÀûÀÎ Ä¡·áÀÇ À¯¿¬¼ºÀ» Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ ÀÚÁÖ ¹æ¹®ÇÏÁö ¾Ê°íµµ ȯÀÚÀÇ °Ç°­À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ½Ç½Ã°£ °Ç°­ ÃßÀûÀº ÀÇ·á ½Ã¼³ÀÇ ºÎ´ãÀ» ÁÙ¿©ÁÙ »Ó¸¸ ¾Æ´Ï¶ó °Ç°­ ÇÕº´ÁõÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â Áúȯ µî Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ °í·ÉÈ­¿Í »ýȰ½À°üº´ Áõ°¡·Î ÀÎÇØ µðÁöÅÐ ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÌ ³Î¸® äÅõǴ °è±â°¡ µÇ¾ú½À´Ï´Ù. º´¿ø ¹× Áø·á¼Ò°¡ ¿ø°ÝÀÇ·á·Î ÀüȯÇϸ鼭 ´ë¸é Á¢ÃËÀ» ÃÖ¼ÒÈ­ÇÏ°í ¹ÙÀÌ·¯½º °¨¿°ÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀüȯÀº ƯÈ÷ À§±â »óȲ¿¡¼­ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ Àåºñ°¡ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖÀ¸¸ç, Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ´Ù´Â Á¡À» ºÎ°¢½ÃÄ×½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ÀåºñÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí Àִ°¡?

µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ¼ºÀåÀÇ ¿øµ¿·ÂÀº Á¤È®¼º, »ç¿ë ÆíÀǼº ¹× ±¤¹üÀ§ÇÑ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ» °­È­ÇÏ´Â ÀÏ·ÃÀÇ ±â¼ú Çõ½ÅÀÔ´Ï´Ù. ÀÌ ºÐ¾ßÀÇ Å« ¹ßÀü Áß Çϳª´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ °³¹ß·Î ¿¹Ãø ºÐ¼®°ú °³ÀÎÈ­µÈ °Ç°­ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â AI ±â¹Ý ¸ð´ÏÅ͸µ Àåºñ´Â ´ë·®ÀÇ µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ºÐ¼®ÇÏ¿© ½É°¢ÇÑ ¹®Á¦·Î ¹ßÀüÇϱâ Àü¿¡ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ÀáÀçÀûÀÎ °Ç°­ À§ÇèÀ» °æ°íÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ °Ç°­ À§ÇèÀ» °æ°íÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î AI ±â¹Ý ½É¹Ú¼ö ¸ð´ÏÅÍ´Â ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀåÁúȯÀÇ Ãʱâ ¡Èĸ¦ °¨ÁöÇÏ¿© Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº ȯÀÚ µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô Àü¼Û ¹× ÀúÀåÇϰí, ÀÇ·á Àü¹®°¡°¡ ¾îµð¼­³ª ½±°Ô µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ¿ø°Ý ¸ð´ÏÅ͸µ ¹× Áø·á Á¶Á¤À» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ±â¼ú µ¿ÇâÀº ¼¾¼­ ±â¼úÀÇ ¼ÒÇüÈ­ ¹× Çâ»óÀÔ´Ï´Ù. ¿þ¾î·¯ºí ±â±â¿¡ ³»ÀåµÈ ¼¾¼­°¡ ´õ¿í Á¤±³ÇØÁ® ½É¹Ú¼ö, »ê¼ÒÆ÷È­µµ, Ç÷¾Ð, Æ÷µµ´ç ¼öÄ¡ µî ´Ù¾çÇÑ »ý¸®Àû ÆÄ¶ó¹ÌÅ͸¦ Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ ¼¾¼­´Â Á¤È®µµ°¡ ³ôÀ» »Ó¸¸ ¾Æ´Ï¶ó ħ½À¼ºÀÌ ³·±â ¶§¹®¿¡ ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºí·çÅõ½º ¹× 5G¿Í °°Àº ¹«¼± ¿¬°á ±â¼úÀÇ ÅëÇÕÀº °Ç°­ µ¥ÀÌÅÍÀÇ ½Ç½Ã°£ Åë½ÅÀ» °­È­ÇÏ¿© º¸´Ù ºü¸£°í ¾ÈÁ¤ÀûÀÎ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿Í µ¿±âÈ­µÇ´Â ¸ð¹ÙÀÏ °Ç°­ ¾ÛÀÇ È®´ë´Â ȯÀÚ°¡ ½º½º·Î °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¿½Ã¿¡ ÀÇ·áÁøÀÌ È¯ÀÚÀÇ »óÅ¿¡ ´ëÇÑ Á¤È®ÇÑ ÃֽŠÁ¤º¸¸¦ ½Ç½Ã°£À¸·Î Á¦°ø¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¼ÒºñÀÚ ¼±È£µµ¿Í ÇコÄÉ¾î ´ÏÁî°¡ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

¼ÒºñÀÚ ÇൿÀº µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Çü¼º¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ƯÈ÷ °³ÀÎÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °Ç°­°ü¸®¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí °Ç°­ ±â¼úÀÇ ÀαⰡ ³ô¾ÆÁö´Â °ÍÀº °³ÀÎÈ­µÈ °Ç°­ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ »çȸ Àü¹ÝÀÇ Ãß¼¼¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ¿À´Ã³¯ ¼ÒºñÀÚµéÀº ½Åü Ȱµ¿À» ÃßÀûÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó °Ç°­ Àü¹Ý¿¡ ´ëÇÑ ´õ ±íÀº ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â ±â±â¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿þ¾î·¯ºí Á¦Á¶¾÷üµéÀº ½ºÆ®·¹½º ¼öÁØ, ¼ö¸éÀÇ Áú, ½ÉÇ÷°ü °Ç°­ »óÅ µî º¸´Ù Á¤±³ÇÑ °Ç°­ ÁöÇ¥¸¦ ±â±â¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒºñÀÚ ¼±È£µµÀÇ º¯È­´Â µðÁöÅÐ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, °¢ ¾÷üµéÀº ½Ç½Ã°£ Á¾ÇÕÀûÀÎ °Ç°­ ÃßÀû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Á¦Ç°À» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¿ø°ÝÀÇ·á¿Í ¿ø°ÝÀÇ·áÀÇ ºÎ»óÀº µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤Åÿ¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ °í·ÉÈ­¿Í ÀÇ·áºñ »ó½ÂÀ» °ü¸®ÇØ¾ß ÇÏ´Â »óȲ¿¡¼­ ¿ø°Ý ¸ð´ÏÅ͸µÀº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ºÎ´ãÀ» ´ú¾îÁÖ´Â ¼Ö·ç¼ÇÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚ¸¦ Áý¿¡¼­ ¸ð´ÏÅ͸µÇÔÀ¸·Î½á ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀ̸鼭 ÇÊ¿äÇÑ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. À̴ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, º´¿ø ¹æ¹®ÀÇ ºÒÆíÇÔ°ú ºÒÆíÇÔÀ» ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, ȯÀÚÀÇ ¸¸Á·µµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Á¦°øµÈ ¼­ºñ½º°¡ ¾Æ´Ñ ȯÀÚÀÇ ¼º°ú¿¡ µû¶ó º¸»óÀ» ¹Þ´Â °¡Ä¡ ±â¹Ý ÀÇ·á ¸ðµ¨ÀÇ È®»êÀº µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ÀÏ»ó Áø·á¿¡ ´ëÇÑ ÅëÇÕÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÇコÄÉ¾î ¸ðµ¨ Àüȯ, ¼ÒºñÀÚ ÇൿÀÇ ÁøÈ­ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ´ç´¢º´, ½ÉÀ庴, È£Èí±â Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î Áö¼ÓÀûÀÎ ½Ç½Ã°£ °Ç°­ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ ¸¸¼ºÁúȯÀ» º¸´Ù È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó »ó½Ã ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÑ µðÁöÅÐ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ °í·ÉÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó °í·É ȯÀÚÀÇ °Ç°­ ¸Å°³º¯¼ö¸¦ ¸ð´ÏÅ͸µÇÏ¿© ÀÇ·áÁøÀÌ Àû½Ã¿¡ °³ÀÔÇϰí ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½´Â ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ȯÀÚ °ü¸®ÀÇ ºÎ»óÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ÀüÅëÀûÀÎ ÀÓ»ó ȯ°æ ÀÌ¿ÜÀÇ Àå¼Ò¿¡¼­ ȯÀÚ¿¡°Ô ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» ¸ð»öÇÏ´Â °¡¿îµ¥, µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ÀÌ·¯ÇÑ ÀüȯÀ» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ¸¦ ¿ø°ÝÀÇ·á Ç÷§Æû¿¡ ÅëÇÕÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡´Â ¿ø°ÝÀ¸·Î ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¸ç, ³ôÀº ¼öÁØÀÇ Áø·á¸¦ À¯ÁöÇϸ鼭 Á÷Á¢ ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹«¼± ¿¬°á°ú ¸ð¹ÙÀÏ Çコ ¿ëµµÀÇ ¹ßÀüÀ¸·Î ÀÇ·áÁøÀÌ ½Ç½Ã°£À¸·Î ȯÀÚ µ¥ÀÌÅÍ¿¡ ½±°Ô Á¢±ÙÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î °³ÀÎÈ­µÈ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä¿Í ¿þ¾î·¯ºí °Ç°­ ±â±âÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ ÀÓ»ó ¹× °¡Á¤ ȯ°æ ¸ðµÎ¿¡¼­ µðÁöÅРȯÀÚ ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ÇâÈÄ ¼ö³â°£ Áö¼ÓÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¿þ¾î·¯ºí µð¹ÙÀ̽º, ¸ð¹ÙÀÏ Çコ, ¹«¼± ¼¾¼­ ±â¼ú, ÅÚ·¹Çコ, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ), Á¦Ç°(Áø´Ü ¸ð´ÏÅ͸µ µð¹ÙÀ̽º, Ä¡·á ¸ð´ÏÅ͸µ µð¹ÙÀ̽º)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Patient Monitoring Devices Market to Reach US$537.8 Billion by 2030

The global market for Digital Patient Monitoring Devices estimated at US$198.2 Billion in the year 2024, is expected to reach US$537.8 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2024-2030. Wearable Devices, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$188.0 Billion by the end of the analysis period. Growth in the mHealth segment is estimated at 21.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$50.4 Billion While China is Forecast to Grow at 23.7% CAGR

The Digital Patient Monitoring Devices market in the U.S. is estimated at US$50.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$142.0 Billion by the year 2030 trailing a CAGR of 23.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 15.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.

Global Digital Patient Monitoring Devices Market - Key Trends & Drivers Summarized

How Are Digital Patient Monitoring Devices Revolutionizing Healthcare?

Digital patient monitoring devices have become an integral part of modern healthcare systems, revolutionizing the way patient health is tracked and managed. These devices are used to continuously monitor vital signs, physical activity, and other health parameters, transmitting real-time data to healthcare providers for timely analysis and intervention. The advent of wearables such as smartwatches, fitness trackers, and advanced medical-grade devices like continuous glucose monitors and ECG monitors has made patient monitoring more accessible, personalized, and accurate. Whether in hospitals, at home, or in remote locations, digital patient monitoring devices offer the flexibility of continuous care, enabling clinicians to monitor patients’ health without the need for frequent in-person visits. This real-time health tracking not only reduces the burden on healthcare facilities but also improves outcomes by allowing early detection of health complications.

The demand for these devices has surged due to the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders, which require continuous monitoring. The global aging population, combined with the increasing incidence of lifestyle-related diseases, is further propelling the adoption of digital monitoring technologies. Additionally, the COVID-19 pandemic acted as a catalyst for the widespread adoption of remote patient monitoring, as hospitals and clinics shifted toward telemedicine to minimize in-person contact and reduce the risk of virus transmission. This transition highlighted the critical role that digital patient monitoring devices play in delivering healthcare services, particularly in times of crisis.

What Technological Innovations Are Driving the Growth of Digital Patient Monitoring Devices?

The growth of digital patient monitoring devices is being driven by a series of technological innovations that enhance their accuracy, usability, and integration with broader healthcare systems. One of the major advancements in this field is the development of artificial intelligence (AI) and machine learning algorithms, which enable predictive analytics and personalized health insights. AI-driven monitoring devices can analyze large amounts of data in real time, alerting healthcare providers to potential health risks before they escalate into serious issues. For instance, AI-powered heart rate monitors can detect early signs of arrhythmias or other cardiac anomalies, allowing for timely intervention. Furthermore, cloud-based platforms are enabling the seamless transmission and storage of patient data, making it easily accessible to healthcare professionals from any location, thus facilitating remote monitoring and care coordination.

Another significant technological trend is the miniaturization and improvement in sensor technology. Sensors embedded in wearable devices have become more sophisticated, offering precise monitoring of various physiological parameters such as heart rate, oxygen saturation, blood pressure, and glucose levels. These sensors are not only more accurate but also less invasive, making patient compliance easier. Moreover, the integration of wireless connectivity technologies like Bluetooth and 5G is enhancing the real-time communication of health data, enabling faster and more reliable monitoring. The expansion of mobile health apps that sync with these devices is also playing a key role in empowering patients to take control of their own health, while ensuring that healthcare providers receive accurate, real-time updates on their patients’ conditions.

How Are Consumer Preferences and Healthcare Needs Shaping the Digital Patient Monitoring Devices Market?

Consumer behavior is playing a pivotal role in shaping the digital patient monitoring devices market, particularly as individuals become more health-conscious and proactive in managing their well-being. The increasing popularity of wearable health technology reflects a broader societal trend toward personalized health monitoring. Consumers today are looking for devices that not only track their physical activity but also provide deeper insights into their overall health. As a result, wearable manufacturers are incorporating more advanced health metrics, such as stress levels, sleep quality, and cardiovascular health, into their devices. This shift in consumer preference is driving innovation in digital monitoring devices, with companies developing products that cater to the growing demand for real-time, holistic health tracking.

Moreover, the rise of remote healthcare and telemedicine has significantly impacted the adoption of digital patient monitoring devices. With healthcare systems around the world under pressure to manage aging populations and rising healthcare costs, remote monitoring is seen as a solution to ease the strain on healthcare providers. Patients with chronic conditions, for example, can be monitored from home, reducing the need for frequent hospital visits while still ensuring that they receive the necessary care. This not only improves patient outcomes but also enhances patient satisfaction, as individuals can avoid the inconvenience and discomfort of hospital visits. The increasing prevalence of value-based healthcare models, where providers are reimbursed based on patient outcomes rather than services rendered, is further driving the integration of digital patient monitoring devices into routine care.

What Factors Are Driving Growth in the Digital Patient Monitoring Devices Market?

The growth in the digital patient monitoring devices market is driven by several factors, including technological advancements, shifting healthcare models, and evolving consumer behavior. One of the primary growth drivers is the increasing prevalence of chronic diseases such as diabetes, heart disease, and respiratory conditions, which necessitate continuous and real-time health monitoring. As healthcare systems focus on managing chronic conditions more effectively, the demand for digital monitoring devices that allow for constant oversight is growing. Additionally, the aging global population is creating a higher demand for devices that monitor health parameters in elderly patients, enabling healthcare providers to deliver timely interventions and improve patient outcomes.

Another critical driver is the rise of telemedicine and remote patient care. As healthcare providers look for ways to offer quality care to patients outside of traditional clinical settings, digital patient monitoring devices have become essential tools in facilitating this transition. The integration of these devices into telemedicine platforms is allowing healthcare professionals to monitor patients remotely, reducing the need for in-person visits while maintaining high standards of care. Moreover, the advancements in wireless connectivity and mobile health applications are making it easier for healthcare providers to access and analyze patient data in real time, further fueling the growth of this market. Finally, consumer demand for personalized healthcare solutions and the increasing popularity of wearable health devices are driving the adoption of digital patient monitoring technologies in both clinical and home settings, positioning the market for sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Digital Patient Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Wearable Devices, mHealth, Wireless Sensor Technology, Telehealth, Remote Patient Monitoring); Product (Diagnostic Monitoring Devices, Therapeutic Monitoring Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 203 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â